Tay-Sachs Disease Treatment Market is segmented By Drug Class (Anticonvulsants, Antipsychotic Medications, Others), By Treatment (Medication, Respiratory Care, Physical Therapy), By Mode of Treatment (Injectable, Oral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
The major players operating in the Tay-Sachs Disease Treatment Market include Recursion Pharmaceuticals, IntraBio Inc, Johnson & Johnson Services Inc, Axovant Services, Sio Gene Therapies, Pfizer Inc, AbbVie Inc, Amgen Inc, Novartis AG and Progenity Inc.
Tay-Sachs Disease Treatment Market